ABVC BioPharma

-$0.05 (-2.40%) Today
+$0.11 (+5.42%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABVC BioPharma and other ETFs, options, and stocks.

About ABVC

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002.

CEO
Howard Doong
Employees
30
Headquarters
Fremont, California
Founded
1990

ABVC Key Statistics

Market cap
65.58M
Price-Earnings ratio
—
Dividend yield
—
Average volume
66.35K
High today
$2.22
Low today
$2.03
Open price
$2.19
Volume
30.02K
52 Week high
$11.69
52 Week low
$1.95

ABVC Earnings

-$0.31
-$0.21
-$0.10
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
Expected May 31, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure